{"id":"doi:10.18553/jmcp.2024.23332","kind":"article","title":"Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes","authors":["Patrick P. Gleason","Benjamin Y. Urick","Landon Marshall","Nicholas J. Friedlander","Yang P. Qiu","R. Scott Leslie"],"author_count":6,"year":2024,"published":"2024-05-08","venue":"Journal of Managed Care & Specialty Pharmacy","cited_by":171,"doi":"10.18553/jmcp.2024.23332","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.18553/jmcp.2024.23332","archive_url":"https://space-kitty.com/papers/doi:10.18553/jmcp.2024.23332","updated":null,"pmid":"38717042","pmcid":null,"openalex_id":"W4396723231","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11293763/pdf/jmcp.2024.23332.pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}